Many health innovations fail at the stage of final clinical testing and are slow to be incorporated into standard care, often not due to the lack of effectiveness, but because of flaws in the design, execution and analysis of the trial. Clinical trials have also become increasingly expensive and take longer to complete as the regulation and governance becomes more burdensome. This is a barrier to successful clinical translation, implementation and ultimately patient access.
We believe this will lead to a more meaningful integration of clinical trials into the Australian health system, resulting in better healthcare and better outcomes for patients, participants and the community as a whole.